Возраст домена | 13 лет |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | 10 |
Страниц в Google | 6460 |
Страниц в Яндексе | 3 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 536195 |
Alexa Country | 143460 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Clinical Leader - Clinical Trials, CRO, Contract Research, eClinical
n/a
Clinical Leader: CRO,Pre-Clinical Contract Research Organization,Bio-Analytical Contract Research Organization,Clinical Contract Research Organization,Pharmacovigilance
UTF-8
69.43 КБ
1 900
15 162 симв.
12 906 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
wikipedia.org | 37 | 9 |
0 | 5 | 6 | |
linkedin.com | 28 | 9 |
0 | 25 | 10 | |
glassdoor.com | 27 | 7 |
0 | 408 | 96 | |
indeed.com | 19 | 8 |
0 | 138 | 50 | |
ema.europa.eu | 18 | 7 |
0 | 687 | 185 | |
centerwatch.com | 16 | 7 |
20 | 117553 | 35782 | |
nih.gov | 16 | 8 |
0 | 113 | 65 | |
arena-international.com | 13 | 4 |
10 | 733223 | 297017 | |
clinicaltrials.gov | 12 | 8 |
375 | 10949 | 4120 | |
youtube.com | 11 | 9 |
0 | 2 | 2 | |
qps.com | 2 | 4 |
0 | 2618046 | Нет данных | |
frontagelab.com | 2 | 4 |
0 | 3729192 | Нет данных | |
eurofinsadmebioanalyses.com | 2 | 3 |
0 | Нет данных | Нет данных | |
criver.com | 2 | 6 |
40 | 98490 | 34835 | |
celerion.com | 2 | 4 |
0 | 1835005 | 418223 | |
bloomingrosefoundation.org | 2 | 3 |
0 | 20305827 | Нет данных | |
biotoxsciences.com | 2 | 5 |
0 | 7296167 | Нет данных | |
admescope.com | 2 | 4 |
0 | 5594581 | Нет данных | |
Еще 32 сайта после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 2 Августа 2014 ) | |
Количество ссылок на сайт | 1219 |
Количество доменов, которые ссылаются на сайт | 40 |
Количество найденных анкоров | 22 |
Исходящие (внешние) ссылки домена | 1310 |
Количество доменов, на которые ссылается сайт | 39 |
Количество исходящих анкоров | 46 |
Внешние ссылки главной страницы ( 16 ) | |
academic.oup.com/jnci/article/111/3/245/5307078 | study |
twitter.com/EdClinical?ref_src=twsrc%5Etfw | Tweets by EdClinical |
bioprocessonline.com/ | BioProcess Online |
biosimilardevelopment.com/ | Biosimilar Development |
cellandgene.com/ | Cell & Gene |
drugdiscoveryonline.com/ | Drug Discovery |
laboratorynetwork.com/ | Laboratory Network |
lifescienceleader.com/ | Life Science Leader Magazine |
meddeviceonline.com/ | Med Device Online |
outsourcedpharma.com | Outsourced Pharma |
pharmaceuticalonline.com/ | Pharmaceutical Online |
cmoleadershipawards.com | CMO Leadership Awards |
croleadershipawards.com/ | CRO Leadership Awards |
outsourcedpharmawest.com/ | Outsourced Pharma Events |
lifesciencetraininginstitute.com | Life Science Training Institute |
vertmarkets.com | VertMarkets, Inc. |
Внутренние ссылки главной страницы ( 84 ) | |
# | - |
/solution/trial-design | Trial Design |
/solution/partnering | Partnering |
/solution/clinical-technologies | Clinical Technologies |
/solution/regulatory | Regulatory |
/solution/clinical-market-research-reports | Market Research |
clinicalleader.com/solution/clinical-leader-editorial-board | Editorial Advisory Board |
/doc/what-exactly-is-a-virtual-clinical-trial-0001 | What Exactly Is A Virtual Clinical Trial? |
/doc/former-novartis-ceo-cell-and-gene-therapies-will-drive-... | Former Novartis CEO: Cell And Gene Therapies Will Drive Innovation |
/doc/success-in-hiv-treatments-creates-additional-challenges... | Success In HIV Treatments Creates Additional Challenges For Drug Developers |
/doc/janssen-uses-a-dashboard-to-monitor-patient-engagement-... | Janssen Uses A Dashboard To Monitor Patient Engagement Progress |
/doc/pfizer-vaccine-trial-focuses-on-pregnant-women-0001 | Pfizer Vaccine Trial Focuses On Pregnant Women |
/doc/will-virtual-trials-mean-the-end-of-cros-0001 | Will Virtual Trials Mean The End Of CROs? |
/doc/rafael-pharmaceuticals-is-starving-cancer-cells-0001 | Rafael Pharmaceuticals Is Starving Cancer Cells |
/doc/less-cumbersome-trials-will-reduce-clinical-costs-timel... | Less Cumbersome Trials Will Reduce Clinical Costs & Timelines |
/doc/berg-invests-in-biology-and-ai-to-drive-new-cures-0001 | BERG Invests In Biology And AI To Drive New Cures |
/doc/can-pharma-move-us-from-sick-care-to-healthy-care-0001 | Can Pharma Move Us From Sick Care To Healthy Care? |
/doc/protocol-deviation-reporting-cutting-through-the-ambigu... | Protocol Deviation Reporting: Cutting Through The Ambiguity |
/doc/the-myth-of-disruptive-innovation-in-clinical-trials-ti... | The Myth Of Disruptive Innovation In Clinical Trials: Time For A More Disciplined Approach |
/doc/putting-patients-first-in-clinical-trial-designs-a-mult... | Putting Patients First In Clinical Trial Designs — A Multifaceted Approach |
/doc/actionable-steps-to-expedite-clinical-trial-agreements-... | 5 Actionable Steps To Expedite Clinical Trial Agreements |
/doc/sop-remediation-when-reinventing-the-wheel-is-the-best-... | SOP Remediation: When Reinventing The Wheel Is The Best Approach |
/doc/tips-for-successful-collaboration-with-your-eu-qualifie... | 4 Tips For Successful Collaboration With Your EU Qualified Person (QP) |
/doc/hybrid-decentralized-trials-using-technology-to-create-... | Hybrid Decentralized Trials: Using Technology To Create More Patient-Centric Studies |
/doc/driving-innovation-blockchain-adoption-for-clinical-tri... | Driving Innovation: Blockchain Adoption For Clinical Trials Optimization |
/hub/bucket/clinical-guest-contributors | More From Our Guest Columnists |
/doc/could-adaptive-designs-be-the-answer-to-oncology-clinic... | Could Adaptive Designs Be The Answer To Oncology Clinical Development Success? |
/doc/top-five-reasons-you-need-irt-expertise-not-just-softwa... | Top Five Reasons You Need IRT Expertise (Not Just Software) |
/doc/can-your-clinical-supply-chain-pass-the-brexit-pressure... | Can Your Clinical Supply Chain Pass The Brexit Pressure Test? |
/doc/ten-tips-for-establishing-the-clinical-utility-of-molec... | Ten Tips For Establishing the Clinical Utility Of Molecular Diagnostics |
/doc/objectively-tracking-lesions-in-dermatology-clinical-tr... | Objectively Tracking Lesions In Dermatology Clinical Trials |
/doc/improving-regulatory-and-operational-performance-in-orp... | Improving Regulatory And Operational Performance In Orphan Drug Development |
/hub/bucket/white-papers-ordered | More Clinical Trial White Papers |
/doc/real-world-evidence-explaining-the-current-state-of-the... | Real-World Evidence: Explaining The Current State Of The FDA’s RWE Program |
/doc/tips-for-fda-submission-0001 | 4 Tips For FDA Submission |
/doc/top-considerations-to-meet-fda-requirements-for-packagi... | Top Considerations To Meet FDA Requirements For Packaging Cryogenically Frozen Advanced Therapies |
/doc/veeva-unified-clinical-operations-survey-report-0001 | Veeva 2019 Unified Clinical Operations Survey Report |
/doc/six-trends-shaping-tomorrow-s-clinical-trials-0001 | Six Trends Shaping Tomorrow's Clinical Trials |
/doc/cro-helps-to-identify-a-highly-productive-location-for-... | CRO Helps To Identify A Highly Productive Location For Siting Future Studies |
/hub/bucket/case-studies-ordered | More Clinical Trial App Notes & Case Studies |
/doc/collaborating-with-patients-3-key-considerations-for-dr... | 11.27.19 -- Collaborating With Patients: 3 Key Considerations For Drug Sponsors |
/doc/clinical-supply-chain-innovations-and-solutions-0001 | 11.26.19 -- Clinical Supply Chain: Innovations And Solutions |
/doc/janssens-lessons-learned-from-digital-health-implementa... | 11.25.19 -- Janssen's Lessons Learned From Digital Health Implementation |
/doc/long-term-follow-up-studies-go-virtual-0002 | 11.21.19 -- Long-Term Follow-Up Studies Go Virtual |
/doc/ai-and-machine-learning-help-unravel-the-biology-of-alz... | 11.20.19 -- AI And Machine Learning Help Unravel The Biology Of Alzheimer's |
/hub/bucket/archivenlmore | More Newsletters |
/static/Legal | Terms of Use |
/static/Privacy | Privacy Statement |
clinicalleader.com/doc/how-patient-centricity-is-changing-cl... | free collection of articles |
solution/clinical-leader-content-collections | More Content Collections |
/doc/collaborating-with-patients-key-considerations-for-drug... | Collaborating With Patients: 3 Key Considerations For Drug Sponsors |
/hub/bucket/focus-on-patients | More From Our Focus on Patients Series |
/doc/patient-engagement-0001 | Patient Engagement |
/doc/yprime-irt-0001 | YPrime IRT+ |
/doc/trial-management-0001 | Trial Management |
/doc/market-research-report-best-practices-in-study-feasibil... | Market Research Report: Best Practices In Study Feasibility |
/doc/site-and-patient-solutions-0001 | Site and Patient Solutions |
/doc/vault-ctms-0001 | Vault CTMS |
/doc/trialscope-transparency-management-0001 | TrialScope Transparency Management |
/doc/patient-protocol-compliance-in-clinical-trials-0001 | Patient & Protocol Compliance In Clinical Trials |
/hub/bucket/HomeEditorsChoice | More Products and Services |
/doc/merck-bayer-investigational-drug-vericiguat-bayer-inves... | Merck And Bayer’s Investigational Drug Vericiguat Meets Primary Endpoint In Phase 3 Study Of Patients With Worsening Chronic Hea... |
/doc/signant-health-clinical-trial-activity-monitoring-patie... | Signant Health And Actigraph Simplify Clinical Trial Activity And Sleep Monitoring For Patients, Sites, And Sponsors With Their ... |
/doc/premier-research-renews-sponsorship-for-world-orphan-dr... | Premier Research Renews Sponsorship For World Orphan Drug Congress Europe |
/doc/signant-health-proud-to-sponsor-the-philadelphia-walk-t... | Signant Health Proud To Sponsor The Philadelphia Walk To End Alzheimer’s In Nationwide Effort To Build Awareness, Raise Funds An... |
/doc/allena-pharmaceuticals-reports-positive-reloxaliase-fro... | Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results From URIROX-1 Trial And From Study 206 |
/hub/bucket/HomeLatestHeadlines | More Industry News |
/eventscalendar/EventDetail/91a5084d-3ccd-4c01-94fb-35ad4002... | Establishing Appropriate Quality Metrics |
/eventscalendar/EventDetail/c86320fd-3d59-4fc4-acf8-682f75b5... | Essentials of Disinfectant Efficacy Testing – Ensuring Microbial Control |
/eventscalendar/EventDetail/c678eff2-ce8a-4737-8a89-77ff3050... | Effective Batch Record Review – Getting It Right The First Time |
/eventscalendar/EventDetail/d2325672-5e6c-4c39-92b7-2b2ef344... | Clinical Research Project Management - 7 Breakthrough Behaviors For Success |
/eventscalendar/EventDetail/4ff76d73-14b3-4dda-b5a6-b58b36eb... | Understanding Aseptic Technique and Cleanroom Behavior – Avoiding Human Error |
clinicalleader.com/eventscalendar | More Industry Events |
clinicalleader.com/doc/life-science-connect-ad-specification... | Ad Specifications |
/doc/media-kit-request-0002 | Request Media Kit |
clinicalleader.com/user/new | Newsletter |
clinicalleader.com/hub/bucket/archivenlmore | Archived Newsletters |
clinicalleader.com/doc/article-reprints-0003 | Article Reprints |
/doc/guest-expert-article-guidelines-0001 | Editorial Submission Guidelines |
clinicalleader.com/solution/clinical-leader-editorial-contri... | Editorial Contributors |
clinicalleader.com/solution/about-clinical-leader | About Us |
clinicalleader.com/solution/contact-clinical-leader | Contact Us |
/static/Copyright | Copyright |
/user-request | Subscriber Request Form |
Domain Name: CLINICALLEADER.COM
Registry Domain ID: 1613466710_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://www.cscglobal.com/global/web/csc/digital-brand-services.html
Updated Date: 2018-08-26T05:34:29Z
Creation Date: 2010-08-30T13:31:19Z
Registry Expiry Date: 2020-08-30T13:31:19Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-1414.AWSDNS-48.ORG
Name Server: NS-1785.AWSDNS-31.CO.UK
Name Server: NS-366.AWSDNS-45.COM
Name Server: NS-538.AWSDNS-03.NET
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-10-19T14:45:28Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
# Robots.txt
# Tells curious robots to go away
# we should update this when we want to let robots in for the home page
# and for news and storefronts
user-agent: *
disallow: /user/
disallow: /user-consent/status
disallow: /User/
disallow: /usersession/
disallow: /UserSession/
disallow: /lead/
disallow: /Lead/
disallow: /nl*
disallow: /submit
disallow: /search
disallow: /Search
disallow: /buyersguide/
disallow: /BuyersGuide/
disallow: /content/rfp/
disallow: /content/associations/
disallow: /content/careercenter/
disallow: /content/membership/
disallow: /education/
disallow: /regform/
disallow: /rfq/
disallow: /RFQ/
disallow: /unifiedshoppingcart/
disallow: /unifiedShoppingCart/
disallow: /content/vertpages/
disallow: /any
disallow: /Any
disallow: /companies
disallow: /bizsolution
disallow: /read
disallow: /Read
disallow: /welcome
disallow: /content/partner/
disallow: /registration/newsletter/
disallow: /Registration/Newsletter/
disallow: /storefronts/
disallow: /track/
disallow: /Track/
disallow: /store
Финляндия - 188.117.16.107
США - 216.239.34.21
США - Маунтин-Вью - 216.239.36.21
США - 216.239.38.21
Nebula Oy
Google
Nebula Oy
Google
HTTP/1.1 200 OK
Cache-Control: no-cache
Pragma: no-cache
Content-Type: text/html; charset=utf-8
Expires: -1
Server: Microsoft-IIS/8.5
X-AspNetMvc-Version: 5.2
X-Frame-Options: SAMEORIGIN
Content-Security-Policy: frame-ancestors 'self'
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Date: Sun, 01 Dec 2019 05:33:18 GMT
Content-Length: 71093
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"